![Uma Sinha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uma Sinha
Technik-/Wissenschafts-/F&E-Leiter bei
EIDOS THERAPEUTICS, INC.
Vermögen: 54 900 $ am 31.05.2026
Profil
Derzeit bekleidet Uma Sinha die Position des Chief Scientific Officer von BridgeBio Pharma, Inc. und des Chief Scientific Officer für Eidos Therapeutics, Inc. (eine Tochtergesellschaft von BridgeBio Pharma, Inc.). Dr. Sinha war zuvor Chief Scientific Officer bei Global Blood Therapeutics, Inc. und Principal bei COR Therapeutics, Inc. sowie Senior Director-Cardiovascular bei Millennium Pharmaceuticals, Inc. und Principal bei Genencor International, Inc. und Vice President & Head-Biology bei Portola Pharmaceuticals, Inc. Sie promovierte an der University of Georgia und erwarb einen Bachelor-Abschluss am Presidency College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROKIDNEY CORP. CLASS A 0,02 % | 28.05.2026 | 30.000 ( 0,02 % ) | 54 900 $ | 31.05.2026 |
Aktive Positionen von Uma Sinha
| Unternehmen | Position | Beginn |
|---|---|---|
| EIDOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 |
| BRIDGEBIO PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2016 |
| PROKIDNEY CORP. | Direktor/Vorstandsmitglied | 01.07.2022 |
Ehemalige bekannte Positionen von Uma Sinha
| Unternehmen | Position | Ende |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2012 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | 01.01.2002 |
| PROKIDNEY A | Direktor/Vorstandsmitglied | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Corporate Officer/Principal | - |
Ausbildung von Uma Sinha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidency College
 Presidency College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Social Capital Suvretta Holdings Corp. III
 Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ProKidney Corp.
 ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
